Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation. (NCT04405518) | Clinical Trial Compass
UnknownPhase 4
Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation.
Spain188 participantsStarted 2019-06-17
Plain-language summary
It is a national multicentre clinical study, where 3 hospitals are involved: Bellvitge University Hospital, Clinic Hospital of Barcelona and Cruces Hospital of Bilbao). It is a randomized study based on the Hemoglobin value of the patient with a 1:1 ratio, parallel groups, controlled and single blind, in patients undergoing an orthotopic liver transplant, confirming previously that the participants fulfill all the inclusion criteria and none of exclusion.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age \> 18 years.
* Candidate to an orthotopic liver trasnplantation.
* Informed consent.
* Preoperative hemoglobine \</= 130 g/L
Exclusion Criteria:
* Preoperative hemoglobin\> 130 g / L
* Familial amyloid polyneuropathy
* Polycystosis hepatic
* Living donor liver transplant
* Uncontrolled donor after cardiac death
* Acute / subacute liver failure
* Re-transplant (in the same hospital admission)
* Use of Anticoagulation drugs before transplantation.
* Age \<18 years.
* Pregnancy and lactation.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Evaluation of the rate of red blood cell packs transfusion during procedure and in the first 24hours after between groups.
Timeframe: Intraoperative and the first 24 hours after surgery.